Meds & supplements › Teriparatide
Medicine · Parathyroid Hormone Analog
Teriparatide injection is indicated: For the treatment of postmenopausal women with osteoporosis at high risk for fracture (defined herein as having a history of osteoporotic fracture or multiple risk factors for fracture) or who have…
Selected manufacturer label information, organised into consistent sections by Sofidex. Read the full label at DailyMed ↗
Teriparatide injection is indicated: For the treatment of postmenopausal women with osteoporosis at high risk for fracture (defined herein as having a history of osteoporotic fracture or multiple risk factors for fracture) or who have failed or are intolerant to other available osteoporosis therapy. In postmenopausal women with osteoporosis, teriparatide injection reduces the risk of vertebral and nonvertebral fractures.
To increase bone mass in men with primary or hypogonadal osteoporosis at high risk for fracture or who have failed or are intolerant to other available osteoporosis therapy. For the treatment of men and women with osteoporosis associated with sustained systemic glucocorticoid therapy (daily dosage equivalent to 5 mg or greater of prednisone) at high risk for fracture or who have failed or are intolerant to other available osteoporosis therapy.
Teriparatide injection is a parathyroid hormone analog, (PTH 1-34), indicated for: Treatment of postmenopausal women with osteoporosis at high risk for fracture or patients who have failed or are intolerant to other available osteoporosis therapy Increase of bone mass in men with primary or hypogonadal osteoporosis at high risk for fracture or patients who have failed or are intolerant to other available osteoporosis therapy Treatment of men and women with osteoporosis associated with sustained systemic glucocorticoid therapy at high risk for fracture or patients who have failed or are intolerant to other available osteoporosis therapy
Cleaning Your BONSITY Delivery Device
Storing Your BONSITY Delivery Device
Revised November 2024
See Reverse Side for More Information
Put your used needles in a FDA-cleared sharps disposal container right away after use.
DO NOT throw away (dispose of) loose needles in your household trash.
If you do not have a FDA-cleared sharps disposal container, you may use a container that is:
When your sharps disposal container is almost full, you will need to follow your community guidelines for the right way to dispose of your sharps disposal container. There may be state or local laws about how you should throw away used needles.
For more information about safe sharps disposal, and for specific information about sharps disposal in the state that you live in, go to the FDA's website at: http://www.fda.gov/safesharpsdisposal.
DO NOT dispose of your used sharps disposal container in your household trash unless your community guidelines permit this.
DO NOT recycle your used sharps disposal container.
Disposal of Pen Needles and the BONSITY Delivery Device
If you have questions or need help with your BONSITY ® delivery device, contact Alvogen, Inc. at 1-866-770-3024 or your healthcare provider. For more information about BONSITY, go to www.bonsity.com.
Distributed by: Alvogen, Inc. Morristown, NJ 07960 USA
BONSITY ® is a registered trademark of Pfenex Inc.
Revised: November 2024 IFU852-00
sofidex [Internet]. Daloreum; c2026. Teriparatide; [reviewed 2026 Aug 3; cited 2026 Nov 10]. Available from: https://sofidex.com/patients/medicines/teriparatide
sofidex. (2026, August 3). Teriparatide. Daloreum. Retrieved November 10, 2026, from https://sofidex.com/patients/medicines/teriparatide
Teriparatide. sofidex. Reviewed August 3, 2026. Accessed November 10, 2026. https://sofidex.com/patients/medicines/teriparatide
The cited date is today’s, because a citation records when you read the page. The reviewed date is when a clinician last checked it.